Int J Arrhythm.  2023 Mar;24(1):3. 10.1186/s42444-023-00085-3.

Is CRT‑D superior to CRT‑P in patients with nonischemic cardiomyopathy?

• Al‑Sadawi M
• Aslam F
• Tao M
• Salam S
• Alsaiqali M
• Singh A
• Fan R
• Rashba E

• KMID: 2541318
• DOI: http://doi.org/10.1186/s42444-023-00085-3

Abstract

Background
Recent studies have questioned the role of implanted cardiac defibrillators (ICDs) in nonischemic cardiomyopathy (NICM). Cardiac resynchronization therapy (CRT) can be delivered by a pacemaker (CRT-P) or an ICD (CRT-D). This meta-analysis assessed the effect of CRT-P versus CRT-D on mortality in patients with NICM.
Methods
Databases were searched for studies reporting the effect of CRT on all-cause mortality in patients with nonischemic cardiomyopathy (Ovid MEDLINE, EMBASE, Scopus, Web of Science, Google Scholar, and EBSCO CINAHL). The primary endpoint was all-cause mortality. The minimum duration of follow-up required for inclusion was one year. The search was not restricted to time or publication status.
Results
The literature search identified 955 candidate studies, 15 studies and 22,763 patients were included. Mean follow-up was 53 months (17–100 months). CRT-D in NICM was associated with lower all-cause mortality (log HR − 0.169, SE 0.055; p = 0.002) compared to CRT-P. Heterogeneity: df = 15 (p 0.03), I2 = 43; test for overall effect: Z = − 3.043 (p = 0.002).
Conclusion
CRT-D in NICM was associated with lower all-cause mortality than CRT-P.

Keyword

CRT-D; CRT-P; Nonischemic cardiomyopathy; Outcomes; Mortality